Market Analysis and Insights: Global Injectable Drug Delivery Technology Market
The global Injectable Drug Delivery Technology market size is projected to reach US$ 61240 million by 2026, from US$ 55130 million in 2020, at a CAGR of 10.3%% during 2021-2026.

Global Injectable Drug Delivery Technology Scope and Market Size
Injectable Drug Delivery Technology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Injectable Drug Delivery Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study

Alkermes
Genentech
Bend Research
QLT
Endocyte
BIND Biosciences
UCB Group (UCB)
Presage Bioscience
Polymer Factory
MicroCHIPS
Pearl Therapeutics
Piedmont Pharmaceuticals
Zogenix
Liquidia Technologies
Impax Laboratories
Boehringer Ingelheim
Crossject Medical Technology
Apogee Technology
Pulmatrix
Medicago

Market segment by Type, the product can be split into

Conventional Drug Delivery
Novel Drug Delivery

Market segment by Application, split into

Cardiovascular Diseases
Diabetes
Regenerative Medicine
Oncology
Pain Management
Hepatitis C
Auto Immune Disorders
Others

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India